The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials

BACKGROUND: The extent of the benefit of bevacizumab combined with chemotherapy in the treatment of advanced non-small-cell lung cancer (NSCLC) is still unclear. We performed this meta-analysis to compare the efficacy of bevacizumab with other commonly used targeted drugs for different patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jianlan, Cai, Xueya, Zhu, Min, Liu, Tianshu, Zhao, Naiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628504/
https://www.ncbi.nlm.nih.gov/pubmed/23614008
http://dx.doi.org/10.1371/journal.pone.0062038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628504/
https://www.ncbi.nlm.nih.gov/pubmed/23614008
http://dx.doi.org/10.1371/journal.pone.0062038

Ejemplares similares